This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-12 and is reviewed periodically as new material appears.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Robert Guillaume (born Robert Peter Williams; November 30, 1927 – October 24, 2017) was an American actor and singer. He played Benson DuBois in the ABC television series Soap and its spin-off, Benson. He also voiced the mandrill Rafiki in The Lion King, and played Isaac Jaffe in Aaron Sorkin's dramedy Sports Night. In a career that spanned more than 50 years, Guillaume worked extensively on stage, television and film. He was nominated for a Tony Award for his portrayal of Nathan Detroit in Guys and Dolls, and twice won an Emmy Award for his portrayal of the character Benson DuBois, once in 1979 on Soap and again in 1985 on Benson. He also won a Grammy Award in 1995 for his spoken-word performance of an audiobook version of The Lion King. Guillaume was the first African-American actor to portray the title role in Andrew Lloyd Webber’s The Phantom of the Opera.
Research on potential current public risk sources is published: the common DBP and BPAF appear to have "substantial impact on the integrity of the sperm nucleus and DNA structure" in mice via oxidative stress (5 May), a preliminary study contextualizes "time spent on social media" as one of the "least influential factors in adolescent mental health" (8 May), ubiquitous environmental contaminant TCE appears to be a risk factor for Parkinson's disease (PD) (15 May), various pesticides are identified as potential risk factors for PD (16 May), researchers demonstrate a two zero-day vulnerabilities-based quick low-cost method – "BrutePrint" – for bypassing common smartphones' fingerprint authentication (18 May), and common sucralose impurity sucralose-6-acetate appears to be DNA damaging with sucralose-sweetened drinks potentially far exceeding the threshold of toxicological concern (29 May). Promising innovations relating to global challenges are demonstrated: an open source automated experimentation science platform (BacterAI) for predicting microbial metabolism with little data (4 May), a pesticide alternative against wheat seed loss (22 May), a low-cost smartphone-attachment (BPClip) for blood pressure measurement (29 May), an open source transfer learning-based system (Geneformer) for predicting how networks of interconnected human genes control or affect the function of cells (31 May).
The earliest kingdoms to emerge in Ghana were Bonoman in the south and the Kingdom of Dagbon in the north, with Bonoman existing in the area during the 11th century. From the 17th century, Akan states began to emerge from what is believed to have been the Bonoman area, mainly based on gold trading. These states included Bonoman (Brong-Ahafo region), Adansi and Asante (Ashanti Region), Denkyira (Western North region), Mankessim Kingdom (Central region), Akyem and Akwamu (Eastern region). By the 19th century, the territory of the southern part of Ghana was included in the Asante Kingdom. The government of the Ashanti Empire operated first as a loose network and eventually as a centralised kingdom with a specialised bureaucracy centred in the capital city of Kumasi. Prior to Akan contact with Europeans, the Akan people created an economy based on principally gold and gold bar precious metals, which were traded with other states in Africa. The Ga-Dangme migrated westward from south-western Nigeria. The Ewe, formerly known as Dogbo, migrated from Ketu (Benin) area with their Gbe-speaking kinsmen (Adja, Fon, Phla/Phera and Ogun/Gun) and, in transition, settled at Tado in Togo, and Dogbo Nyigbo in Benin Republic, with Nortsie (a walled town in what later is Togo) as their final dispersal point. Their dispersal from Nortsie was necessitated by the high-handed rule of King Agorkorli (Agɔ Akɔli), who was the reigning monarch of the tribe at that time.
=== Spread === E. floccosum can remain viable for long periods of time by producing arthroconidia in skin scales. Arthroconidia are thick-walled spores with higher resistance to drying and heat conditions than mycelium. Arthroconidia formation allows E. floccosum to survive for years in showers, baths, swimming pools, towels, blankets, sheets, shoes and other clothing. The fungus commonly spreads by contact in showers and gym facilities.
== Dosage comparison == For constant pain, the relieving effect of extended-release morphine given once (for Kadian) or twice (for MS Contin) every 24 hours is roughly the same as multiple administrations of immediate release (or "regular") morphine. Morphine sulfate pentahydrate (trade names including Dolcontin) has a higher molecular mass than morphine base, and therefore 10 mg morphine sulfate pentahydrate contains approximatively 7.5 mg of morphine free base. Extended-release morphine can be administered together with "rescue doses" of immediate-release morphine pro re nata in case of breakthrough pain, each generally consisting of 5% to 15% of the 24-hour extended-release dosage.
Sources: en.wikipedia.org
=== Distribution === The apparent oral volume of distribution (VSS/F) at steady state of (R)-bicalutamide with oral administration of a single 5 to 80 mg dose of (R)-bicalutamide in a novel solid dispersion with a polymeric matrix of hydroxypropyl methylcellulose phthalate (HP55S) (also known as (R)-bicalutamide/HP55S) ranges from 22.53 ± 3.71 L to 25.38 ± 2.69 L. Bicalutamide is highly protein-bound (96.1% for racemic bicalutamide, 99.6% for (R)-bicalutamide), mainly to albumin. It has negligible affinity for SHBG and no affinity for corticosteroid-binding globulin. The tissue distribution of bicalutamide is not well-characterized. However, it has been reported that distribution studies with bicalutamide have shown that preferential (i.e., tissue-selective) accumulation in anabolic (e.g., muscle) tissues does not occur. There are no available data on hepatic bicalutamide concentrations in humans, but a rat study found that oral bicalutamide treatment resulted in 4-fold higher concentrations of the drug in the liver relative to plasma (a common finding with orally administered drugs, due to transfer through the hepatic portal system prior to reaching circulation). In men receiving 150 mg/day bicalutamide, concentrations of (R)-bicalutamide in semen were 4.9 μg/mL (11 μmol/L), and the amount of the drug that could potentially be delivered to a female partner during sexual intercourse is regarded as low (estimated at 0.3 μg/kg) and below the amount that is required to induce changes in the offspring of laboratory animals.
Eucalyptus Health is an Australian digital health company founded in 2019 that operates telehealth services including Pilot (men's health), Juniper (women's weight management and menopause), Software (dermatology), and Kin (reproductive health). The company is headquartered in Sydney and has expanded to the United Kingdom, Germany, Japan and Canada. Eucalyptus is the first telehealth company in Australia accredited by the Australian Council on Healthcare Standards (ACHS) against EQuIP6 standards for safety and quality of clinical services.
The chemical nature of the stationary phase. The stationary phase can be coated with some ligands at different bonding densities (how many ligands are bonded per surface area). The composition of the mobile phase. The mobile phase may be made of one solvent, or a mixture of several solvents. The solvents can be mixed at different ratios. Different mobile phases have different properties, such as polarity. When a mobile phase consists of mostly one solvent, with some other solvents added in small amounts, those other solvents are called "mobile phase modifiers". The pH of the mobile phase, which affect the ionization state of the solutes and their polarity. This can be changed with additives such as buffers. Usually, the stationary phase is made of a layer of hydrophobic substrate bonded to the surface of porous silica gel particles. The particles come in various shapes (spheric, irregular), at different diameters (sub-2, 3, 5, 7, 10 μm), with varying pore diameters (60, 100, 150, 300 Å). The particle diameters are often given as mesh numbers. For example, 2500-mesh corresponds to a particle diameter of 5 μm. The hydrophobic substrates are generally alkyl chains, such as C3, C4, C8, C18, or more. The longer the chain, the longer the sample components will be retained. It would make the resolution power higher, but also make the chromatography take longer to run. Most current methods of separation of biomedical materials use C18 columns, sometimes called by trade names, such as ODS (octadecylsilane) or RP-18 (reverse phase 18).
In 1970, she established what was for nearly a decade the only protein crystallography laboratory in Israel. Then, from 1979 to 1984 she was a group leader with Heinz-Günter Wittmann at the Max Planck Institute for Molecular Genetics in Berlin. She was a visiting professor at the University of Chicago in 1977–78. She headed a Max-Planck Institute Research Unit at DESY in Hamburg, Germany (1986–2004) in parallel to her research activities at the Weizmann Institute. She focused on the mechanisms underlying protein biosynthesis, by ribosomal crystallography, a research line she pioneered over 20 years ago despite considerable skepticism of the international scientific community. Ribosomes translate RNA into protein and because they have slightly different structures in microbes, when compared to eukaryotes, such as human cells, they are often a target for antibiotics. In 1993, she visualized the path taken by the nascent proteins, namely the ribosomal tunnel, and recently revealed the dynamics elements enabling its involvement in elongation arrest, gating, intra-cellular regulation and nascent chain trafficking into their folding space. In 2000 and 2001, she determined the complete high-resolution structures of both ribosomal subunits and discovered within the otherwise asymmetric ribosome, the universal symmetrical region that provides the framework and navigates the process of polypeptide polymerization.
== Analysis == In simple manual columns, the eluent is collected in constant volumes, known as fractions. The more similar the particles are in size the more likely they are in the same fraction and not detected separately. More advanced columns overcome this problem by constantly monitoring the eluent.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.